Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

MLAB vs SYPR: stock comparison and AI forecast

Mesa Laboratories Inc /Co/ (MLAB) and Sypris Solutions Inc (SYPR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Industrial Instruments For Measurement, Display, and Control

MLAB Mesa Laboratories Inc /Co/

Price
$128.25 +20.9% · 6M
Market Cap
$718M
P/E Ratio
150.8x
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Industrial Instruments For Measurement, Display, and Control

SYPR Sypris Solutions Inc

Price
$1.22 -62.2% · 6M
Market Cap
$28M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

5075100125
MLAB +20.9% SYPR -62.2%
MLAB · SYPR

Key facts

  • MLAB is 25.5 times larger than SYPR by market capitalization ($718M against $28M).
  • Over the last six months MLAB returned +20.9% and SYPR -62.2%.
  • MLAB turns 1.9% of its revenue into net income, against -9.2% for SYPR.
  • SYPR carries 7.97 times debt per unit of equity, against 1.22 times for MLAB.
  • MLAB yields 0.49% in dividends; SYPR pays none.
  • Both companies share the SEC industry classification Industrial Instruments For Measurement, Display, and Control.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMLABSYPR
Market Cap$718M$28M
P/E Ratio150.77x–
P/B Ratio3.80x2.40x
Dividend Yield0.49%–
EPS$0.85$-0.33
Book Value/Share$33.73$0.51
Revenue/Share$44.63$5.00
FCF/Share$9.45$-0.13

Profitability & Margins

MetricMLABSYPR
ROE2.5%-90.6%
ROA1.1%-10.1%
ROIC6.2%-25.6%
Gross Margin64.2%5.4%
Operating Margin9.0%-9.6%
Net Margin1.9%-9.2%
EBT Margin3.8%-9.6%
Tax Rate48.7%3.9%

Financial Health

MetricMLABSYPR
Current Ratio1.79x1.26x
Quick Ratio1.32x0.44x
D/E Ratio1.22x7.97x
Financial Leverage2.22x8.97x
Interest Coverage0.3x0.1x
Working Capital$46M$16M

Cash Flow

MetricMLABSYPR
Operating Cash Flow$56M-$2M
Free Cash Flow$53M-$3M
Capital Spending-$3M-$1M
OCF Growth YoY45.5%–
FCF Growth YoY56.0%–
FCF/Sales21.2%-2.6%
CapEx/Sales1.1%1.0%

Operational Efficiency

MetricMLABSYPR
Asset Turnover0.60x1.09x
Receivables Turnover7.3x11.0x
Inventory Turnover3.3x2.1x
Fixed Assets Turnover8.3x7.4x
Days Sales Outstanding50 days33 days
Days Inventory111 days169 days
Payables Period30 days42 days
Cash Conversion Cycle131 days161 days

Income Statement

MetricMLABSYPR
Total Revenue$250M$115M
Operating Income$22M-$11M
Net Income$5M-$11M
R&D Expense$20M–
SG&A Expense$118M$17M
Cost of Goods Sold$89M$109M

Dividend & Shareholder Information

MetricMLABSYPR
Dividends Per Share$0.63–
Payout Ratio74.1%–
Shares Outstanding6M23M
FAQ

MLAB vs SYPR: stock comparison and AI forecast

Which is bigger, MLAB or SYPR?

MLAB is 25.5 times larger than SYPR by market capitalization ($718M against $28M).

Which stock performed better over the last six months, MLAB or SYPR?

Over the last six months MLAB returned +20.9% and SYPR -62.2%.

Which one does Intratio's AI model rank higher, MLAB or SYPR?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.